ID: ALA3818938

Max Phase: Preclinical

Molecular Formula: C31H30ClNO12S3

Molecular Weight: 703.77

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)c1csc(=S)s1)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl

Standard InChI:  InChI=1S/C31H29NO12S3.ClH/c1-11-24(34)14(32)6-19(43-11)44-16-8-31(40,18(33)9-42-29(39)17-10-46-30(45)47-17)7-13-21(16)28(38)23-22(26(13)36)25(35)12-4-3-5-15(41-2)20(12)27(23)37;/h3-5,10-11,14,16,19,24,34,36,38,40H,6-9,32H2,1-2H3;1H/t11-,14-,16-,19-,24+,31-;/m0./s1

Standard InChI Key:  KPPYJXRELWYYCD-FJRGFWAKSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

U2OS 164939 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA topoisomerase II alpha 6317 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

H9c2 3506 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 703.77Molecular Weight (Monoisotopic): 703.0852AlogP: 2.72#Rotatable Bonds: 7
Polar Surface Area: 212.14Molecular Species: BASEHBA: 16HBD: 5
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.00CX Basic pKa: 9.03CX LogP: 3.48CX LogD: 3.05
Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.11Np Likeness Score: 1.08

References

1. Chegaev K, Rolando B, Cortese D, Gazzano E, Buondonno I, Lazzarato L, Fanelli M, Hattinger CM, Serra M, Riganti C, Fruttero R, Ghigo D, Gasco A..  (2016)  H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.,  59  (10): [PMID:27120394] [10.1021/acs.jmedchem.6b00184]

Source